AD113 / Apnimed - LARVOL DELTA

Trial of AD113 and Atomoxetine in OSA Patients With Hypertension (clinicaltrials.gov) - P2 | N=21 | Completed | Sponsor: Apnimed | Active, not recruiting ➔ Completed

Trial completion • Cardiovascular • Hypertension • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder

Trial of AD113 and Atomoxetine in OSA Patients With Hypertension (clinicaltrials.gov) - P2 | N=21 | Active, not recruiting | Sponsor: Apnimed | Recruiting ➔ Active, not recruiting | N=15 ➔ 21

Enrollment change • Enrollment closed • Cardiovascular • Hypertension • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder

Trial of AD113 and Atomoxetine in OSA Patients With Hypertension (clinicaltrials.gov) - P2 | N=15 | Recruiting | Sponsor: Apnimed | Trial completion date: Mar 2022 ➔ Mar 2023 | Trial primary completion date: Jan 2022 ➔ Jan 2023

Trial completion date • Trial primary completion date • Cardiovascular • Hypertension • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder